Fig. 2From: Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinomaA–D A comparison of distribution as seen in different clinical features of the two molecular subtypes in the TCGA dataset; E comparison between metabolic subtypes and existing molecular subtypes; F distribution comparison between different metabolic subtypes; G KM curve of OS time between existing immune molecular subtypes; H KM curve of DSS time between existing immune molecular subtypesBack to article page